Larotrectinib Drug Encyclopedia

Larotrectinib is a targeted therapy drug that is a tyrosine kinase inhibitor. Its main role is to fight tumors carrying NTRK gene fusions, including adult and pediatric patients. NTRKGene fusion is a rare genetic abnormality that has been found in a variety of cancers, such as soft tissue sarcoma, infantile fibroma, lung cancer, etc.

Larotrectinib is unique in its highly selective targetingNTRKkinase. NTRKkinase is involved in regulating cell growth and differentiation under normal circumstances, but in the case of NTRK gene fusion, the activity of the kinase loses normal regulation, resulting in abnormal cell proliferation and survival signaling, thus promoting the development of tumors. By inhibiting NTRK kinase, larotrectinib can effectively block this abnormal signaling pathway and inhibit tumor growth.

Clinical trial results show that larotrectinib has shown significant efficacy in patients carryingNTRK gene fusions, including tumor shrinkage, stopping progression, and even complete disappearance. The safety of the drug has also been rigorously evaluated, and common adverse reactions include fatigue, dizziness, nausea and other mild side effects.

Before using larotrectinib, patients usually need to undergo genetic testing to determine whether their tumors carryNTRK gene fusions to determine whether they are suitable for treatment with this drug. Therefore, larotrectinib provides an innovative and personalized treatment option for patients with tumors carrying NTRK gene fusions.

Larotrectinib has been launched in China and has not yet been included in medical insurance. Since it has not been launched in China for a long time, it may be difficult to purchase it in hospitals. For specific conditions, it is recommended to consult the local hospital pharmacy. In foreign markets, larotinib has two options: original drug and generic drug. Original drugs include the German version, the American version, the European version and the Hong Kong version, and the price is about 10,000 to 20,000 yuan. In comparison, generic drugs are much cheaper. There are Lao and Bangladeshi versions of generic drugs, and the price is around two to three thousand. It is worth noting that the ingredients of original drugs and generic drugs are basically the same.